ASX:GTG Genetic Technologies (GTG) Stock Price, News & Analysis → Strange new buyer driving up gold (From Stansberry Research) (Ad) Free GTG Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield8.62%Price TargetN/A Stock AnalysisStock Analysis Get Genetic Technologies alerts: Email Address Ad Stansberry ResearchStrange new buyer driving up goldOne Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."But there's a much better move you can make to get in front of these big moves today. About Genetic Technologies Stock (ASX:GTG)Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, and type 2 diabetes. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.Read More Ad Stansberry ResearchStrange new buyer driving up goldOne Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."But there's a much better move you can make to get in front of these big moves today. GTG Stock News HeadlinesApril 18, 2024 | stockhouse.comGeneType Clinicians' Adoption Growing - Sales up 5-Fold Year on YearApril 17, 2024 | finance.yahoo.comNew Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment OutcomesApril 19, 2024 | Stansberry Research (Ad)Strange new buyer driving up goldOne Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."April 16, 2024 | finance.yahoo.comGeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on YearApril 11, 2024 | finance.yahoo.comGTG to pilot GeneType in Breast Screen centers across the U.S.April 10, 2024 | stockhouse.comEVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk"March 31, 2024 | msn.comDeer with 'rare' genetic mutation photographed in Oregon: See pics hereMarch 22, 2024 | msn.comDecoding the shared genetic toolkit for male sex determinationApril 19, 2024 | Stansberry Research (Ad)Strange new buyer driving up goldOne Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."March 20, 2024 | msn.comAnalytic tool rapidly reveals genetic diversity for next-generation crop breedingMarch 12, 2024 | msn.comCreate Regional Genetic Store, EA Community ToldMarch 9, 2024 | msn.comUnraveling the Canine Genetic Code Navigating the Landscape of Dog DNA TestingMarch 8, 2024 | finance.yahoo.comOne Genetic Technologies Insider Raised Stake By 20% In Previous YearFebruary 28, 2024 | msn.comGenetic studies shed light on hypertension risk but fall short of revealing new treatmentsFebruary 22, 2024 | msn.comUnraveling the genetic and environmental influences on trustFebruary 20, 2024 | msn.comNovel genetic associations with anxiety unveiled in comprehensive study of over 1.2 million peopleFebruary 19, 2024 | msn.comStudy highlights importance of genetic sequencing to diagnosis of growth disordersFebruary 19, 2024 | reuters.comUS study uncovers 275 million entirely new genetic variantsFebruary 17, 2024 | msn.comExome sequencing unravels complex genetic diagnoses in growth disordersFebruary 15, 2024 | msn.comJournal retracts over dozen ‘unethical’ genetic studies conducted in China on minority groupsFebruary 8, 2024 | msn.comGenetic Diseases to be Detected in Fetus; State-of-the-art Technology at Sabine Hospital, KeralaFebruary 5, 2024 | msn.comChinese genetic study seeks to make generational medical discoveriesJanuary 17, 2024 | msn.comResearchers uncover the role of inherited genetic variants in rare type of blood cancerJanuary 16, 2024 | msn.comWe must not rush to implement new genetic screening programs, experts warnJanuary 9, 2024 | msn.comLargest genetic study of gestational diabetes discovers nine novel genetic regions linked to severe and common pregnancy complicationJanuary 6, 2024 | seekingalpha.comGENE Genetic Technologies LimitedJanuary 5, 2024 | finance.yahoo.comGenetic Technologies Regains Compliance with Nasdaq Minimum Bid Price RequirementSee More Headlines Receive GTG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genetic Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:GTG CUSIPN/A CIKN/A Webwww.gtglabs.com Phone61 3 8412 7000FaxN/AEmployees60Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-12,710,000.00 Net Margins-124.08% Pretax MarginN/A Return on Equity-160.47% Return on Assets-52.71% Debt Debt-to-Equity Ratio7.95 Current Ratio1.67 Quick Ratio3.72 Sales & Book Value Annual Sales$10.24 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.04 per share Price / BookN/AMiscellaneous Outstanding Shares115,420,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.33 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Simon MorrissChief Executive OfficerMr. Carl S. Stubbings BScChief Commercial OfficerMr. Kevin CamilleriChief Executive Officer of EasyDNAMs. Kathryn J. E. Andrews B.Com (Age 57)CPA, Chief Financial Officer & Company Secretary Mr. Paul Keith Mathieson Viney B. BusFCI, FCPA, FGIA, ConsultantKey CompetitorsANGLEOTCMKTS:ANPCYAustralian Clinical LabsASX:ACLBARD1 Life SciencesASX:BD1BCAL DiagnosticsASX:BDXbioAffinity TechnologiesNASDAQ:BIAFWView All CompetitorsInsidersPeter RubinsteinBought 617,209 shares on 3/6/2024Total: $80,237.17 ($0.13/share)Jerzy (George) MuchnickiSold 57,500,000 sharesTotal: $8.63 M ($0.15/share) GTG Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Genetic Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Genetic Technologies investors own include Viralytics (VRACY) and Orthocell (OCC). This page (ASX:GTG) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 MediaMy biggest AI fearParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetic Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.